Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian T Anderson

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Bjpsych Bulletin|January 13, 2016
'Spirituality' and 'cultural adaptation' in a Latino mutual aid group for substance misuse and mental healthBrian T Anderson, Angela Garcia
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 21, 2023
Psychedelic therapies reconsidered: compounds, clinical indications, and cautious optimismJennifer M Mitchell, Brian T Anderson
Journal of Psychoactive Drugs|October 16, 2023
Psychedelic Research and Therapeutic Practices: Embracing Communities, Groups, and Traditional KnowledgeVeronica Magar, Julian Urrutia, Brian T Anderson
JAMA Neurology|January 16, 2024
Psychedelics in Addiction Treatment-Navigating a Sociopolitical RiftNicky J Mehtani, Brian T Anderson, Jennifer M Mitchell
The Lancet. Psychiatry|September 19, 2020
Psychedelic medicine: safety and ethical concernsBrian T Anderson, Alicia L Danforth, Charles S Grob
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 30, 2009
Enhanced sensitivity of the MRL/MpJ mouse to the neuroplastic and behavioral effects of chronic antidepressant treatmentsDarrick T Balu, Georgia E Hodes, Brian T Anderson, et al.
ACS Pharmacology & Translational Science|April 16, 2021
Psilocybin-Assisted Group Therapy and Attachment: Observed Reduction in Attachment Anxiety and Influences of Attachment Insecurity on the Psilocybin ExperienceChristopher S Stauffer, Brian T Anderson, Kile M Ortigo, et al.
Journal of Psychoactive Drugs|January 27, 2022
Comment and Response: (Lugo-Radillo & Cortez-Lopez, 2020) Long-Term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-Containing MushroomsCiarán Martin Fitzpatrick, Brian T Anderson, Gabrielle Agin-Liebes, et al.
Drug and Alcohol Dependence|March 8, 2026
Trends in first-time psychedelic and other hallucinogen use in the United States: Results from the National Survey on Drug Use and HealthJuan Carlos C Montoy, Ralph C Wang, Allison R Coker, et al.
Scientific Reports|August 2, 2024
Psilocybin-assisted therapy and HIV-related shameNicky J Mehtani, Mallory O Johnson, Peter S Hendricks, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Bjpsych Bulletin|January 13, 2016
'Spirituality' and 'cultural adaptation' in a Latino mutual aid group for substance misuse and mental healthBrian T Anderson, Angela Garcia
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 21, 2023
Psychedelic therapies reconsidered: compounds, clinical indications, and cautious optimismJennifer M Mitchell, Brian T Anderson
Journal of Psychoactive Drugs|October 16, 2023
Psychedelic Research and Therapeutic Practices: Embracing Communities, Groups, and Traditional KnowledgeVeronica Magar, Julian Urrutia, Brian T Anderson
JAMA Neurology|January 16, 2024
Psychedelics in Addiction Treatment-Navigating a Sociopolitical RiftNicky J Mehtani, Brian T Anderson, Jennifer M Mitchell
The Lancet. Psychiatry|September 19, 2020
Psychedelic medicine: safety and ethical concernsBrian T Anderson, Alicia L Danforth, Charles S Grob
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 30, 2009
Enhanced sensitivity of the MRL/MpJ mouse to the neuroplastic and behavioral effects of chronic antidepressant treatmentsDarrick T Balu, Georgia E Hodes, Brian T Anderson, et al.
ACS Pharmacology & Translational Science|April 16, 2021
Psilocybin-Assisted Group Therapy and Attachment: Observed Reduction in Attachment Anxiety and Influences of Attachment Insecurity on the Psilocybin ExperienceChristopher S Stauffer, Brian T Anderson, Kile M Ortigo, et al.
Journal of Psychoactive Drugs|January 27, 2022
Comment and Response: (Lugo-Radillo & Cortez-Lopez, 2020) Long-Term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-Containing MushroomsCiarán Martin Fitzpatrick, Brian T Anderson, Gabrielle Agin-Liebes, et al.
Drug and Alcohol Dependence|March 8, 2026
Trends in first-time psychedelic and other hallucinogen use in the United States: Results from the National Survey on Drug Use and HealthJuan Carlos C Montoy, Ralph C Wang, Allison R Coker, et al.
Scientific Reports|August 2, 2024
Psilocybin-assisted therapy and HIV-related shameNicky J Mehtani, Mallory O Johnson, Peter S Hendricks, et al.
Pageof 3